Identification of the estrogen receptor beta as a possible new tamoxifen-sensitive target in diffuse large B-cell lymphomaMyra Langendonk, Tom van Meerten|Blood Cancer Journal|2022Cited by 20
Navitoclax Most Promising BH3 Mimetic for Combination Therapy in Hodgkin LymphomaMyra Langendonk, Lydia Visser|International Journal of Molecular Sciences|2022Cited by 5